Search Our Site

News filed in:

"Uncategorized"

The largest healthcare company in the US is sounding the alarm on a new kind of emergency room that charges 20 times more than a regular doctor visit

Emergency rooms that aren’t attached to hospitals have been popping up around the US, especially in the suburbs of cities like Houston and Austin. The centers can offer a more convenient alternative to long wait times in a hospital’s emergency department, or waiting for a visit with your regular doctor. The centers can also be... Read More »

Read More →

Emergency rooms that aren’t attached to hospitals have been popping up around the US, especially in the suburbs of cities like Houston and Austin. The centers can offer a more convenient alternative to long wait times in a hospital’s emergency department, or waiting for a visit with your regular doctor. The centers can also be… Read More »

[...]

Read More

Drugmakers open new year with price increases on dozens of medicines

Dive Brief: Several major drugmakers, including Allergan, Bristol-Myers Squibb and Eli Lilly, increased prices on a number of their drugs Jan. 1, holding with typical industry practice despite continuing scrutiny of rising pharmaceutical costs. Relative to its pharma peers, Allergan moved most aggressively, upping the list price of Linzess, Lo Loestrin and 25 other medicines... Read More »

Read More →

Dive Brief: Several major drugmakers, including Allergan, Bristol-Myers Squibb and Eli Lilly, increased prices on a number of their drugs Jan. 1, holding with typical industry practice despite continuing scrutiny of rising pharmaceutical costs. Relative to its pharma peers, Allergan moved most aggressively, upping the list price of Linzess, Lo Loestrin and 25 other medicines… Read More »

[...]

Read More

CAR T therapies show durable responses, potential benefits from combinations

The dawn of regulator-approved chimeric antigen receptor (CAR) T-cell therapies, such as Kymriah (tisagenlecleucel, Novartis AG), have provided doctors with important new options for treating people with several types of aggressive blood cancers. But how long the new therapies can help and whether their costs can be made sustainable remain open questions. New research presented... Read More »

Read More →

The dawn of regulator-approved chimeric antigen receptor (CAR) T-cell therapies, such as Kymriah (tisagenlecleucel, Novartis AG), have provided doctors with important new options for treating people with several types of aggressive blood cancers. But how long the new therapies can help and whether their costs can be made sustainable remain open questions. New research presented… Read More »

[...]

Read More

Colorectal Cancer Screening Pill to Be in US Pilot Study

Check-Cap received CE mark for its C-Scan Capsule in January of this year, now the Isfiya, Israel-based company is setting its sights on the U.S. market. Check-Cap is getting one step closer to having its capsule-based screening method for colorectal cancer on the U.S. market. The Isfiya, Israel-based company has received FDA conditional approval for... Read More »

Read More →

Check-Cap received CE mark for its C-Scan Capsule in January of this year, now the Isfiya, Israel-based company is setting its sights on the U.S. market. Check-Cap is getting one step closer to having its capsule-based screening method for colorectal cancer on the U.S. market. The Isfiya, Israel-based company has received FDA conditional approval for… Read More »

[...]

Read More

Amid shocks and burns, spinal-cord stimulators are more dangerous than many patients know

In this Nov. 16, 2018, photo, Jim Taft watches The History Channel from the confines of his bed at his home in West Columbia, S.C. Mr. Taft has experienced debilitating health issues after a neurosurgeon implanted Boston Scientific’s Precision spinal cord stimulator in his back in 2014.  (AP photo/Sean Rayford)   COLUMBIA, South Carolina —... Read More »

Read More →

In this Nov. 16, 2018, photo, Jim Taft watches The History Channel from the confines of his bed at his home in West Columbia, S.C. Mr. Taft has experienced debilitating health issues after a neurosurgeon implanted Boston Scientific’s Precision spinal cord stimulator in his back in 2014.  (AP photo/Sean Rayford)   COLUMBIA, South Carolina —… Read More »

[...]

Read More

AI tool predicts Alzheimer’s more than 6 years ahead of diagnosis

A deep learning algorithm developed using imaging data from more than 1,000 Alzheimer’s disease (AD) patients can accurately predict the presence of AD more than six years before a doctor finalizes a diagnosis, researchers reported in Radiology Nov. 6. While it’s globally acknowledged that a timely diagnosis is linked to prognosis in Alzheimer’s patients, physicians... Read More »

Read More →

A deep learning algorithm developed using imaging data from more than 1,000 Alzheimer’s disease (AD) patients can accurately predict the presence of AD more than six years before a doctor finalizes a diagnosis, researchers reported in Radiology Nov. 6. While it’s globally acknowledged that a timely diagnosis is linked to prognosis in Alzheimer’s patients, physicians… Read More »

[...]

Read More

Avoidable hospital-acquired conditions spark $2 billion in extra costs

By Harris Meyer | October 22, 2018 A set of 14 hospital-acquired conditions that the CMS considers avoidable accounted for 48,771 adverse patient outcomes, 3,219 deaths and more than $2 billion in excess hospital costs in 2016, according to a new research brief. Patients experiencing these hospital-acquired conditions (HACs) were in the hospital about 8... Read More »

Read More →

By Harris Meyer | October 22, 2018 A set of 14 hospital-acquired conditions that the CMS considers avoidable accounted for 48,771 adverse patient outcomes, 3,219 deaths and more than $2 billion in excess hospital costs in 2016, according to a new research brief. Patients experiencing these hospital-acquired conditions (HACs) were in the hospital about 8… Read More »

[...]

Read More

Senators Unveil Legislation To Protect Patients Against Surprise Medical Bills

% Quality Assurance With frustration growing among Americans who are being charged exorbitant prices for medical treatment, a bipartisan group of senators Tuesday unveiled a plan to protect patients from surprise bills and high charges from hospitals or doctors who are not in their insurance networks. The draft legislation, which sponsors said is designed to... Read More »

Read More →

% Quality Assurance With frustration growing among Americans who are being charged exorbitant prices for medical treatment, a bipartisan group of senators Tuesday unveiled a plan to protect patients from surprise bills and high charges from hospitals or doctors who are not in their insurance networks. The draft legislation, which sponsors said is designed to… Read More »

[...]

Read More

Hospitals Prepare To Launch Their Own Drug Company To Fight High Prices and Shortages

Sometimes IV bags are hard for hospitals to come by. Other times it’s injectable folic acid to treat anemias. Right now the tissue-numbing agent lidocaine is in short supply. Shortages of commonplace generic drugshave plagued hospitals in recent years. And with short supplies and fewer suppliers for key drugs, there have been price increases. Hospital... Read More »

Read More →

Sometimes IV bags are hard for hospitals to come by. Other times it’s injectable folic acid to treat anemias. Right now the tissue-numbing agent lidocaine is in short supply. Shortages of commonplace generic drugshave plagued hospitals in recent years. And with short supplies and fewer suppliers for key drugs, there have been price increases. Hospital… Read More »

[...]

Read More

Study finds multiple sclerosis drug slows brain shrinkage

  An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Robert J. Fox, M.D., Cleveland Clinic, OH. Results from a clinical trial of more than 250 participants with progressive multiple sclerosis(MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study... Read More »

Read More →

  An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Robert J. Fox, M.D., Cleveland Clinic, OH. Results from a clinical trial of more than 250 participants with progressive multiple sclerosis(MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study… Read More »

[...]

Read More

Page 1 of 5

Categories
Archives